{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:07:43Z","timestamp":1792267663177,"version":"4.4.0"},"reference-count":245,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neulet.2023.137532","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T15:29:46Z","timestamp":1697815786000},"page":"137532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches"],"prefix":"10.1016","volume":"817","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0308-9032","authenticated-orcid":false,"given":"Amirreza","family":"Gholami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10284","key":"10.1016\/j.neulet.2023.137532_b0005","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2023.137532_b0010","article-title":"Alzheimer's disease","author":"Schachter","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113320","article-title":"Alzheimer\u2019s disease and its treatment by different approaches: A review","volume":"216","author":"Srivastava","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0020","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1515\/revneuro-2020-0072","article-title":"Lifestyle intervention to prevent Alzheimer\u2019s disease","volume":"31","author":"Ko","year":"2020","journal-title":"Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0025","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer\u2019s disease","volume":"4","author":"Liu","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.neulet.2023.137532_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147342","article-title":"History in perspective: How Alzheimer's Disease came to be where it is?","volume":"1758","author":"Ahmed","year":"2021","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0040","doi-asserted-by":"crossref","first-page":"e479","DOI":"10.1016\/S2666-7568(21)00140-9","article-title":"Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis","volume":"2","author":"Liang","year":"2021","journal-title":"The Lancet Healthy Longevity"},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1041610222000813","article-title":"Paired associative stimulation (PAS) and Alzheimer\u2019s disease (AD)","volume":"35","author":"Tampi","year":"2023","journal-title":"Int. Psychogeriatr."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/biostatistics\/kxab014","article-title":"Semiparametric regression analysis of bivariate censored events in a family study of Alzheimer\u2019s disease","volume":"24","author":"Gao","year":"2023","journal-title":"Biostatistics"},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b0055","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jalz.2015.05.008","article-title":"The worldwide Alzheimer's disease neuroimaging initiative: an update","volume":"11","author":"Hendrix","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","article-title":"Alzheimer\u2019s disease genetics: from the bench to the clinic","volume":"83","author":"Karch","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2023.137532_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132669","article-title":"Exploring the interaction of clonazepam and diazepam with tau protein: Multispectral and molecular docking studies","volume":"1258","author":"Gholami","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0070","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-129599","article-title":"Probing the Interactions of Lamotrigine and Phenobarbital with Tau Protein: Experimental and Molecular Modeling Studies","volume":"21","author":"Gholami","year":"2022","journal-title":"Iranian Journal of Pharmaceutical Research"},{"key":"10.1016\/j.neulet.2023.137532_b0075","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijbiomac.2020.11.192","article-title":"Review on Alzheimer's disease: inhibition of amyloid beta and tau tangle formation","volume":"167","author":"Ashrafian","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neulet.2023.137532_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/17590914211051908","article-title":"Innate immunity and cell death in Alzheimer's disease","volume":"13","author":"Lee","year":"2021","journal-title":"ASN Neuro"},{"issue":"5","key":"10.1016\/j.neulet.2023.137532_b0085","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jocn.2003.12.007","article-title":"Alzheimer\u2019s disease pathogenesis and therapeutic interventions","volume":"11","author":"Parihar","year":"2004","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0090","series-title":"Seminars in Cell & Developmental Biology","article-title":"The therapeutic potential of the neuroactive peptides of soluble amyloid precursor protein-alpha in Alzheimer\u2019s disease and related neurological disorders","author":"Mockett","year":"2023"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.60084\/hjas.v1i1.12","article-title":"QSAR Classification of Beta-Secretase 1 Inhibitor Activity in Alzheimer's Disease Using Ensemble Machine Learning Algorithms","volume":"1","author":"Noviandy","year":"2023","journal-title":"Heca Journal of Applied Sciences"},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3390\/biom13020313","article-title":"The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells","volume":"13","author":"Cai","year":"2023","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/bios11080255","article-title":"Optical imaging of beta-amyloid plaques in Alzheimer\u2019s disease","volume":"11","author":"Luo","year":"2021","journal-title":"Biosensors"},{"key":"10.1016\/j.neulet.2023.137532_b0110","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.04.024","article-title":"Tau aggregation","volume":"518","author":"Hern\u00e1ndez","year":"2023","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0115","doi-asserted-by":"crossref","first-page":"e22702","DOI":"10.1096\/fj.202201197R","article-title":"Boosting of tau protein aggregation by CD40 and CD48 gene expression in Alzheimer's disease","volume":"37","author":"Kim","year":"2023","journal-title":"FASEB J."},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0120","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/antiox10091479","article-title":"Oxidative stress and beta amyloid in Alzheimer\u2019s disease. Which comes first: The chicken or the egg?","volume":"10","author":"Tamagno","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13073-022-01022-0","article-title":"PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease","volume":"14","author":"Tsai","year":"2022","journal-title":"Genome Med."},{"key":"10.1016\/j.neulet.2023.137532_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117253","article-title":"Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease","volume":"421","author":"Bhatia","year":"2021","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0135","article-title":"Memory loss in Alzheimer's disease","author":"Jahn","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.neulet.2023.137532_b0140","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","article-title":"Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group","volume":"20","author":"Dubois","year":"2021","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.neulet.2023.137532_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bandl.2021.105041","article-title":"Language changes in Alzheimer\u2019s disease: A systematic review of verb processing","volume":"223","author":"Williams","year":"2021","journal-title":"Brain Lang."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0150","doi-asserted-by":"crossref","first-page":"e2938","DOI":"10.1002\/brb3.2938","article-title":"Personality traits and disorders in Alzheimer's disease","volume":"13","author":"Henriques-Calado","year":"2023","journal-title":"Brain and Behavior"},{"key":"10.1016\/j.neulet.2023.137532_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101891","article-title":"Apathy in Alzheimer\u2019s disease: A Neurocircuitry Based Perspective","author":"Mehak","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0160","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/biomedicines11020335","article-title":"The future of precision medicine in the cure of Alzheimer\u2019s disease","volume":"11","author":"Arafah","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.neulet.2023.137532_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101721","article-title":"An integrative machine-learning meta-analysis of high-throughput omics data identifies age-specific hallmarks of Alzheimer\u2019s disease","author":"Shokhirev","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0170","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3390\/ijms23041989","article-title":"Aging, cellular senescence, and Alzheimer\u2019s disease","volume":"23","author":"Liu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0175","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/ijms24043754","article-title":"Alzheimer\u2019s Disease: An Updated Overview of Its Genetics","volume":"24","author":"Andrade-Guerrero","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0180","first-page":"313","article-title":"The epidemiology of Alzheimer\u2019s disease modifiable risk factors and prevention","volume":"8","author":"Zhang","year":"2021","journal-title":"J. Prev Alzheimers Dis."},{"key":"10.1016\/j.neulet.2023.137532_b0185","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fcimb.2020.00104","article-title":"The links between the gut microbiome, aging, modern lifestyle and Alzheimer's disease","volume":"10","author":"Askarova","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.neulet.2023.137532_b0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fnagi.2019.00369","article-title":"Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer\u2019s disease","volume":"11","author":"Bhatti","year":"2020","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0195","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ggi.14357","article-title":"Alcohol consumption and risk of Alzheimer's disease: A dose\u2013response meta-analysis","volume":"22","author":"Xie","year":"2022","journal-title":"Geriatr. Gerontol. Int."},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0200","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/jgs.16275","article-title":"The risk of head injuries associated with antipsychotic use among persons with Alzheimer's disease","volume":"68","author":"Tapiainen","year":"2020","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.neulet.2023.137532_b0205","first-page":"1","article-title":"If Midlife Brain Injury Is a Risk Factor for Alzheimer\u2019s Disease and Related Dementias, What Is the Neuropathologic Mechanism?","author":"White","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0210","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/jacsau.2c00572","article-title":"The Role of Heme and Copper in Alzheimer\u2019s Disease and Type 2 Diabetes Mellitus","volume":"3","author":"Pal","year":"2023","journal-title":"JACS Au"},{"key":"10.1016\/j.neulet.2023.137532_b0215","article-title":"Mechanistic and etiological similarities in diabetes mellitus and Alzheimer\u2019s disease: Antidiabetic drugs as optimistic therapeutics in Alzheimer\u2019s disease","author":"Das","year":"2023","journal-title":"CNS & Neurological Disorders-Drug Targets (formerly Current Drug Targets-CNS & Neurological Disorders)"},{"key":"10.1016\/j.neulet.2023.137532_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/4981814","article-title":"Metabolism: a novel shared link between diabetes mellitus and Alzheimer\u2019s disease","author":"Sun","year":"2020","journal-title":"Journal of Diabetes Research"},{"key":"10.1016\/j.neulet.2023.137532_b0225","doi-asserted-by":"crossref","first-page":"1065335","DOI":"10.3389\/fneur.2022.1065335","article-title":"Blood pressure and Alzheimer's disease: A review of meta-analysis","volume":"13","author":"S\u00e1iz-Vazquez","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neulet.2023.137532_b0230","doi-asserted-by":"crossref","unstructured":"Sible, I.J., D.A. Nation, and A.s.D.N. Initiative, Long-term blood pressure variability across the clinical and biomarker spectrum of Alzheimer\u2019s disease. Journal of Alzheimer's Disease, 2020. 77(4): p. 1655-1669.","DOI":"10.3233\/JAD-200221"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0235","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13760-021-01664-8","article-title":"The circadian rhythm of arterial blood pressure in Alzheimer\u2019s disease and vascular dementia","volume":"123","author":"Daniela","year":"2023","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.neulet.2023.137532_b0240","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/febs.16344","article-title":"Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise","volume":"290","author":"Yin","year":"2023","journal-title":"FEBS J."},{"key":"10.1016\/j.neulet.2023.137532_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.690372","article-title":"Cholesterol and Alzheimer\u2019s disease; from risk genes to pathological effects","volume":"13","author":"Feringa","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0250","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1111\/ejn.14758","article-title":"Obesity and Alzheimer\u2019s disease: Molecular bases","volume":"52","author":"Picone","year":"2020","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104852","article-title":"Environmental toxins and Alzheimer's disease progression","volume":"141","author":"Vasefi","year":"2020","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2023.137532_b0260","doi-asserted-by":"crossref","first-page":"1149776","DOI":"10.3389\/fnmol.2023.1149776","article-title":"Effects of environmental toxins on brain health and development","volume":"16","author":"Kumar","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.128238","article-title":"The association between toxic pesticide environmental exposure and Alzheimer\u2019s disease: A scientometric and visualization analysis","volume":"263","author":"Li","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.neulet.2023.137532_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117203","article-title":"Predicting Alzheimer's disease progression using deep recurrent neural networks","volume":"222","author":"Nguyen","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2023.137532_b0275","doi-asserted-by":"crossref","unstructured":"Schermer, M.H. Preclinical disease or risk factor? Alzheimer\u2019s disease as a case study of changing conceptualizations of disease. in The Journal of Medicine and Philosophy: A Forum for Bioethics and Philosophy of Medicine. 2023. Oxford University Press US.","DOI":"10.1093\/jmp\/jhad009"},{"key":"10.1016\/j.neulet.2023.137532_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101544","article-title":"Biomarkers used in Alzheimer\u2019s disease diagnosis, treatment, and prevention","volume":"74","author":"Mahaman","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0285","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/alz.12737","article-title":"Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials","volume":"19","author":"Langbaum","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0290","doi-asserted-by":"crossref","first-page":"e12179","DOI":"10.1002\/trc2.12179","article-title":"Alzheimer's disease drug development pipeline: 2021","volume":"7","author":"Cummings","year":"2021","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.1016\/j.neulet.2023.137532_b0295","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1017\/S2045796019000702","article-title":"Alzheimer's disease medication and outcomes of hospitalisation among patients with dementia","volume":"29","author":"M\u00f6llers","year":"2020","journal-title":"Epidemiol. Psychiatr. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0300","doi-asserted-by":"crossref","DOI":"10.1111\/psyg.12944","article-title":"Aducanumab for the treatment of Alzheimer's disease: a systematic review","author":"Rahman","year":"2023","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.neulet.2023.137532_b0305","doi-asserted-by":"crossref","unstructured":"Agarwal, K., D.P. Katare, and R. Jakhmola-Mani, Foresee novel targets for Alzheimer\u2019s disease by investigating repurposed drugs. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 2023.","DOI":"10.2174\/1871527321666220622162622"},{"key":"10.1016\/j.neulet.2023.137532_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.hsr.2023.100075","article-title":"FORMULATION STRATEGIES FOR NOSE-TO-BRAIN DRUG DELIVERY IN ALZHEIMER'S DISEASE","author":"Vohra","year":"2023","journal-title":"Health Sciences Review"},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0315","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0320","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/brain\/awad005","article-title":"Anti-amyloid antibody therapies in Alzheimer\u2019s disease","volume":"146","author":"Perneczky","year":"2023","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0325","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","author":"Alzheimer's disease facts and figures","year":"2021","journal-title":"Alzheimers Dement."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0330","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1257\/jel.20211660","article-title":"What can economics say about Alzheimer\u2019s Disease?","volume":"61","author":"Chandra","year":"2023","journal-title":"J. Econ. Lit."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0335","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules27041210","article-title":"Amyloidosis in Alzheimer\u2019s disease: Pathogeny, etiology, and related therapeutic directions","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0340","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1042\/BST20201022","article-title":"Methods to study the structure of misfolded protein states in systemic amyloidosis","volume":"49","author":"F\u00e4ndrich","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neulet.2023.137532_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00755-7","article-title":"Associations of Alzheimer\u2019s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration","volume":"13","author":"Tan","year":"2021","journal-title":"Alzheimers Res. Ther."},{"issue":"5","key":"10.1016\/j.neulet.2023.137532_b0350","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10741-021-10164-z","article-title":"The genetics of cardiac amyloidosis","volume":"27","author":"Arno","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"16","key":"10.1016\/j.neulet.2023.137532_b0355","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.3390\/molecules26165091","article-title":"Significance of oligomeric and fibrillar species in amyloidosis: insights into pathophysiology and treatment","volume":"26","author":"Koike","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.neulet.2023.137532_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113270","article-title":"Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy","volume":"225","author":"Andrade","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.neulet.2023.137532_b0365","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1134\/S0006297920090035","article-title":"Amyloid and amyloid-like aggregates: Diversity and the term crisis","volume":"85","author":"Matiiv","year":"2020","journal-title":"Biochem. Mosc."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0370","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-022-01356-1","article-title":"The amyloid plaque proteome in early onset Alzheimer\u2019s disease and Down syndrome","volume":"10","author":"Drummond","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0375","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000506696","article-title":"The pathology of amyloidosis in classification: a review","volume":"143","author":"Picken","year":"2020","journal-title":"Acta Haematol."},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0380","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4239\/wjd.v7.i9.189","article-title":"Neuroendocrine hormone amylin in diabetes","volume":"7","author":"Zhang","year":"2016","journal-title":"World J. Diabetes"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-018-0034-3","article-title":"Systemic immunoglobulin light chain amyloidosis","volume":"4","author":"Merlini","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.neulet.2023.137532_b0390","series-title":"Serum amyloid A (SAA) proteins","first-page":"421","author":"Sack","year":"2020"},{"issue":"16","key":"10.1016\/j.neulet.2023.137532_b0395","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1074\/jbc.R115.639799","article-title":"Systemic amyloidosis: lessons from \u03b22-microglobulin","volume":"290","author":"Stoppini","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2023.137532_b0400","first-page":"e54060","article-title":"Correlative light and electron microscopy to study microglial interactions with \u03b2-amyloid plaques","volume":"112","author":"Bisht","year":"2016","journal-title":"JoVE (journal of Visualized Experiments)"},{"key":"10.1016\/j.neulet.2023.137532_b0405","unstructured":"Takacs, K., et al., Opening Amyloid-Windows to the Secondary Structure of Proteins: The Amyloidogenecity Increases Tenfold Inside Beta-Sheets. arXiv preprint arXiv:2210.11842, 2022."},{"issue":"5","key":"10.1016\/j.neulet.2023.137532_b0410","doi-asserted-by":"crossref","first-page":"e12941","DOI":"10.1111\/bpa.12941","article-title":"Accumulation of cellular prion protein within \u03b2-amyloid oligomer plaques in aged human brains","volume":"31","author":"Takahashi","year":"2021","journal-title":"Brain Pathol."},{"issue":"581","key":"10.1016\/j.neulet.2023.137532_b0415","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neulet.2023.137532_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.609073","article-title":"Modulation of \u03b2-amyloid fibril formation in Alzheimer\u2019s disease by microglia and infection","volume":"13","author":"Brown","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0425","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2023.02.078","article-title":"Plasminogen decreases A\u03b242 and Tau deposition, and shows multi-beneficial effects on Alzheimer's disease in mice and humans","volume":"654","author":"Guo","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neulet.2023.137532_b0430","series-title":"Implications of heparan sulfate and heparanase in amyloid diseases","first-page":"631","author":"Li","year":"2020"},{"key":"10.1016\/j.neulet.2023.137532_b0435","article-title":"Heparan Sulfate in Alzheimer's Disease: Aberrant expression and functions in molecular pathways related to amyloid-\u03b2 metabolism. American Journal of physiology. Cell","author":"McMillan","year":"2023","journal-title":"Physiology"},{"issue":"53","key":"10.1016\/j.neulet.2023.137532_b0440","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1002\/chem.202000782","article-title":"Extracellular matrix proteins involved in Alzheimer's disease. Chemistry\u2013A","volume":"26","author":"Ma","year":"2020","journal-title":"European Journal"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12987-020-00219-y","article-title":"The microvascular extracellular matrix in brains with Alzheimer\u2019s disease neuropathologic change (ADNC) and cerebral amyloid angiopathy (CAA)","volume":"17","author":"Damodarasamy","year":"2020","journal-title":"Fluids and Barriers of the CNS"},{"key":"10.1016\/j.neulet.2023.137532_b0450","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.601320","article-title":"The role of basement membranes in cerebral amyloid angiopathy","volume":"11","author":"Howe","year":"2020","journal-title":"Front. Physiol."},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0455","doi-asserted-by":"crossref","first-page":"5453","DOI":"10.1111\/ejn.15372","article-title":"The role of extracellular matrix alterations in mediating astrocyte damage and pericyte dysfunction in Alzheimer's disease: A comprehensive review","volume":"56","author":"Anwar","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.neulet.2023.137532_b0465","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.3390\/ijms22063015","article-title":"A comparative study of the effects of platinum (II) complexes on \u03b2-amyloid aggregation: Potential neurodrug applications","volume":"22","author":"Manna","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0470","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-020-00205-2","article-title":"Nucleo\u2013cytoplasmic transport defects and protein aggregates in neurodegeneration","volume":"9","author":"Bitetto","year":"2020","journal-title":"Translational Neurodegeneration"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0475","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/brainsci10040232","article-title":"Do post-translational modifications influence protein aggregation in neurodegenerative diseases: a systematic review","volume":"10","author":"Schaffert","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0480","series-title":"Seminars in Cell & Developmental Biology","article-title":"Successive cleavage of \u03b2-amyloid precursor protein by \u03b3-secretase","author":"Funamoto","year":"2020"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0485","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3934\/Neuroscience.2019.4.273","article-title":"\u03b2-Amyloid precursor protein (APP) and the human diseases","volume":"6","author":"Nguyen","year":"2019","journal-title":"AIMS Neuroscience"},{"key":"10.1016\/j.neulet.2023.137532_b0490","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fphys.2020.01056","article-title":"New insights into blood-brain barrier maintenance: the homeostatic role of \u03b2-amyloid precursor protein in cerebral vasculature","volume":"11","author":"Ristori","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neulet.2023.137532_b0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2021.103624","article-title":"Artesunate restores the levels of inhibitory synapse proteins and reduces amyloid-\u03b2 and C-terminal fragments (CTFs) of the amyloid precursor protein in an AD-mouse model","volume":"113","author":"Kiss","year":"2021","journal-title":"Mol. Cell. Neurosci."},{"issue":"14","key":"10.1016\/j.neulet.2023.137532_b0500","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1021\/jacs.1c10533","article-title":"Mechanism of tripeptide trimming of amyloid \u03b2-peptide 49 by \u03b3-secretase","volume":"144","author":"Bhattarai","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0505","doi-asserted-by":"crossref","first-page":"e0276933","DOI":"10.1371\/journal.pone.0276933","article-title":"Patients with Alzheimer\u2019s disease have an increased removal rate of soluble beta-amyloid-42","volume":"17","author":"Zaretsky","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2023.137532_b0510","first-page":"1","article-title":"Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma A\u03b2 40\/42 Ratio as a Biomarker of Amyloid-\u03b2 Amyloidosis in Alzheimer\u2019s Disease","volume":"Preprint","author":"Nakamura","year":"2023","journal-title":"J. Alzheimers Dis."},{"issue":"11","key":"10.1016\/j.neulet.2023.137532_b0515","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1038\/s41380-019-0410-8","article-title":"Familial Alzheimer\u2019s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta","volume":"25","author":"Arber","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"43","key":"10.1016\/j.neulet.2023.137532_b0520","doi-asserted-by":"crossref","first-page":"30144","DOI":"10.1039\/C6CP04925G","article-title":"Conformational features of the A\u03b2 42 peptide monomer and its interaction with the surrounding solvent","volume":"18","author":"Khatua","year":"2016","journal-title":"PCCP"},{"issue":"6","key":"10.1016\/j.neulet.2023.137532_b0525","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/jnc.15007","article-title":"A mechanistic hypothesis for the impairment of synaptic plasticity by soluble A\u03b2 oligomers from Alzheimer\u2019s brain","volume":"154","author":"Li","year":"2020","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2023.137532_b0530","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"\u03b2-Amyloid peptides and amyloid plaques in Alzheimer\u2019s disease","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0535","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s13361-019-02283-7","article-title":"Metal ion binding to the amyloid \u03b2 monomer studied by native top-down FTICR mass spectrometry","volume":"30","author":"Lermyte","year":"2019","journal-title":"J. Am. Soc. Mass Spectrom."},{"key":"10.1016\/j.neulet.2023.137532_b0540","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s12551-019-00606-2","article-title":"Recent advances in the design and applications of amyloid-\u03b2 peptide aggregation inhibitors for Alzheimer\u2019s disease therapy","volume":"11","author":"Jokar","year":"2019","journal-title":"Biophys. Rev."},{"issue":"5","key":"10.1016\/j.neulet.2023.137532_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101267","article-title":"Distinct conformers of amyloid beta accumulate in the neocortex of patients with rapidly progressive Alzheimer's disease","volume":"297","author":"Liu","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0550","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsb.2010.09.018","article-title":"Amyloid structure and assembly: insights from scanning transmission electron microscopy","volume":"173","author":"Goldsbury","year":"2011","journal-title":"J. Struct. Biol."},{"issue":"7376","key":"10.1016\/j.neulet.2023.137532_b0555","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nature10577","article-title":"Atomic-resolution dynamics on the surface of amyloid-\u03b2 protofibrils probed by solution NMR","volume":"480","author":"Fawzi","year":"2011","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.neulet.2023.137532_b0560","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.3390\/molecules27248804","article-title":"Oligomer Formation by Amyloid-\u03b242 in a Membrane-Mimicking Environment in Alzheimer\u2019s Disease","volume":"27","author":"Rosenberry","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0565","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12551-021-00903-9","article-title":"Structural biology of cell surface receptors implicated in Alzheimer\u2019s disease","volume":"14","author":"Hermans","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.neulet.2023.137532_b0570","series-title":"A computational study of interactions between amyloid-\u03b2 and transition metals via molecular dynamics","author":"Kennedy-Britten","year":"2022"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0575","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/ijms22041859","article-title":"Promotion and inhibition of amyloid-\u03b2 peptide aggregation: Molecular Dynamics Studies","volume":"22","author":"Itoh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0580","doi-asserted-by":"crossref","first-page":"34","DOI":"10.9734\/ijbcrr\/2020\/v29i130163","article-title":"The essentials of biochemistry of the proteins as related to Alzheimer\u2019s disease: A review","volume":"29","author":"Prasad","year":"2020","journal-title":"International Journal of Biochemistry Research & Review"},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0585","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1248\/bpb.b21-00204","article-title":"Amyloid Beta-Peptide 25\u201335 (A\u03b225\u201335) Induces Cytotoxicity via Multiple Mechanisms: Roles of the Inhibition of Glucosylceramide Synthase by A\u03b225\u201335 and Its Protection by D609","volume":"44","author":"Tang","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0590","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s42003-020-0865-9","article-title":"Why does the A\u03b2 peptide of Alzheimer share structural similarity with antimicrobial peptides?","volume":"3","author":"Pastore","year":"2020","journal-title":"Communications Biology"},{"issue":"22","key":"10.1016\/j.neulet.2023.137532_b0595","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1046\/j.1432-1033.2002.03271.x","article-title":"Solution structure of the Alzheimer amyloid \u03b2-peptide (1\u201342) in an apolar microenvironment: Similarity with a virus fusion domain","volume":"269","author":"Crescenzi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.neulet.2023.137532_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2022.108143","article-title":"Molecular docking and molecular dynamics simulations studies on the protective and pathogenic roles of the amyloid-\u03b2 peptide between herpesvirus infection and Alzheimer's disease","volume":"113","author":"Wang","year":"2022","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.neulet.2023.137532_b0605","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3389\/fnins.2019.01154","article-title":"The beta amyloid dysfunction (BAD) hypothesis for Alzheimer\u2019s disease","volume":"13","author":"Hillen","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111623","article-title":"Advances in developing therapeutic strategies for Alzheimer's disease","volume":"139","author":"Nguyen","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"16","key":"10.1016\/j.neulet.2023.137532_b0615","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.3390\/ijms23169041","article-title":"The Chemerin\/CMKLR1 Axis Is Involved in the Recruitment of Microglia to A\u03b2 Deposition through p38 MAPK Pathway","volume":"23","author":"Chen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0620","first-page":"1","article-title":"MicroRNA-650 regulates the pathogenesis of Alzheimer\u2019s Disease through targeting Cyclin-Dependent Kinase 5","author":"Lin","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0625","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/1567202617666200128141938","article-title":"MiR-335-5p inhibits \u03b2-amyloid (A\u03b2) accumulation to attenuate cognitive deficits through targeting c-jun-N-terminal kinase 3 in Alzheimer\u2019s disease","volume":"17","author":"Wang","year":"2020","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.neulet.2023.137532_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.124231","article-title":"A\u03b2-oligomers: A potential therapeutic target for Alzheimer's disease","author":"Ghosh","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0635","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","article-title":"Galectin-3 promotes A\u03b2 oligomerization and A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Tao","year":"2020","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0640","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1021\/acs.accounts.1c00055","article-title":"Current strategies for modulating A\u03b2 aggregation with multifunctional agents","volume":"54","author":"Du","year":"2021","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.neulet.2023.137532_b0645","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s12640-019-00116-9","article-title":"\u03b2-Amyloid peptide: The cell compartment multi-faceted interaction in Alzheimer\u2019s disease","volume":"37","author":"Picone","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neulet.2023.137532_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101496","article-title":"Past, present and future of therapeutic strategies against amyloid-\u03b2 peptides in Alzheimer\u2019s disease: A systematic review","volume":"72","author":"Jeremic","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.neulet.2023.137532_b0655","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.brainresbull.2021.10.008","article-title":"MicroRNA-455\u20135p\/CPEB1 pathway mediates A\u03b2-related learning and memory deficits in a mouse model of Alzheimer\u2019s disease","volume":"177","author":"Xiao","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"22","key":"10.1016\/j.neulet.2023.137532_b0660","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1002\/cmdc.202100428","article-title":"Formaldehyde-Crosslinked Nontoxic A\u03b2 Monomers to Form Toxic A\u03b2 Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives","volume":"16","author":"Zhao","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.neulet.2023.137532_b0665","doi-asserted-by":"crossref","first-page":"1040576","DOI":"10.3389\/fnagi.2022.1040576","article-title":"Late-long-term potentiation magnitude, but not A\u03b2 levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease","volume":"14","author":"Yesiltepe","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108122","article-title":"Physiology and pharmacology of amyloid precursor protein","author":"Cho","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.neulet.2023.137532_b0675","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3390\/membranes11120983","article-title":"Secretases Related to Amyloid Precursor Protein Processing","volume":"11","author":"Liu","year":"2021","journal-title":"Membranes"},{"issue":"6","key":"10.1016\/j.neulet.2023.137532_b0680","first-page":"1","article-title":"Radiological-prognostic correlation of diffusion tensor imaging in a mild traumatic brain injury model","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp. Ther. Med."},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0685","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1134\/S0006297922080028","article-title":"Effect of tau protein on mitochondrial functions","volume":"87","author":"Epremyan","year":"2022","journal-title":"Biochem. Mosc."},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0690","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s12031-022-02002-0","article-title":"The role of post-translational modifications on the structure and function of tau protein","volume":"72","author":"Ye","year":"2022","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.neulet.2023.137532_b0695","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.3390\/molecules28114544","article-title":"Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status","volume":"28","author":"Pinzi","year":"2023","journal-title":"Molecules"},{"issue":"46","key":"10.1016\/j.neulet.2023.137532_b0700","doi-asserted-by":"crossref","first-page":"10391","DOI":"10.1002\/chem.202000246","article-title":"Review and prospect: deep learning in nuclear magnetic resonance spectroscopy. Chemistry\u2013A","volume":"26","author":"Chen","year":"2020","journal-title":"European Journal"},{"issue":"20","key":"10.1016\/j.neulet.2023.137532_b0705","doi-asserted-by":"crossref","first-page":"7839","DOI":"10.1021\/jacs.1c03314","article-title":"Inclusion of the C-terminal domain in the \u03b2-sheet core of heparin-fibrillized three-repeat tau protein revealed by solid-state nuclear magnetic resonance spectroscopy","volume":"143","author":"Dregni","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b0710","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1021\/acs.jpclett.1c04185","article-title":"Saponins form nonionic lipid nanodiscs for protein structural studies by Nuclear Magnetic Resonance Spectroscopy","volume":"13","author":"McCalpin","year":"2022","journal-title":"The Journal of Physical Chemistry Letters"},{"key":"10.1016\/j.neulet.2023.137532_b0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.01.009","article-title":"Tau protein aggregation: key features to improve drug discovery screening","author":"Giovannini","year":"2022","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b0720","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.4103\/1673-5374.332127","article-title":"Amyloid-beta peptide and tau protein crosstalk in Alzheimer\u2019s disease","volume":"17","author":"Roda","year":"2022","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neulet.2023.137532_b0725","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.586169","article-title":"Molecular imaging of tau protein: New insights and future directions","volume":"13","author":"Pizzarelli","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0730","doi-asserted-by":"crossref","first-page":"204","DOI":"10.3389\/fnagi.2019.00204","article-title":"Role of tau as a microtubule-associated protein: structural and functional aspects","volume":"11","author":"Barbier","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0735","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3389\/fnagi.2019.00322","article-title":"Enhanced tau protein translation by hyper-excitation","volume":"11","author":"Kobayashi","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0740","doi-asserted-by":"crossref","first-page":"8870","DOI":"10.1038\/s41598-023-36073-9","article-title":"Effects of three microtubule-associated proteins (MAP2, MAP4, and Tau) on microtubules\u2019 physical properties and neurite morphology","volume":"13","author":"Nishida","year":"2023","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0745","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","article-title":"Tauopathies: New perspectives and challenges","volume":"17","author":"Zhang","year":"2022","journal-title":"Mol. Neurodegener."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0750","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/D1CS00127B","article-title":"Revisiting the grammar of Tau aggregation and pathology formation: how new insights from brain pathology are shaping how we study and target Tauopathies","volume":"51","author":"Limorenko","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.neulet.2023.137532_b0755","first-page":"1","article-title":"Arsenic and Tau Phosphorylation: a Mechanistic Review","author":"Ariafar","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.neulet.2023.137532_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103487","article-title":"Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies","author":"Moore","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0765","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101442","article-title":"Post-translational modifications within tau paired helical filament nucleating motifs perturb microtubule interactions and oligomer formation","volume":"298","author":"Acosta","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neulet.2023.137532_b0770","doi-asserted-by":"crossref","first-page":"26a","DOI":"10.1016\/j.bpj.2022.11.363","article-title":"Katanin activity in tau envelopes negatively correlates with ATP levels","volume":"122","author":"Grycova","year":"2023","journal-title":"Biophys. J ."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0775","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3390\/biomedicines10040760","article-title":"The Role of Tau beyond Alzheimer\u2019s Disease: A Narrative Review","volume":"10","author":"Virgilio","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.neulet.2023.137532_b0780","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2022.05.023","article-title":"Macromolecular structures and proteins interacting with the microtubule associated tau protein","volume":"518","author":"Jim\u00e9nez","year":"2023","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2023.137532_b0785","doi-asserted-by":"crossref","unstructured":"Boyko, S., K. Surewicz, and W.K. Surewicz, Regulatory mechanisms of tau protein fibrillation under the conditions of liquid\u2013liquid phase separation. Proceedings of the National Academy of Sciences, 2020. 117(50): p. 31882-31890.","DOI":"10.1073\/pnas.2012460117"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0790","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3390\/cells10040721","article-title":"GSK-3 and Tau: a key duet in Alzheimer\u2019s disease","volume":"10","author":"Sayas","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b0795","doi-asserted-by":"crossref","first-page":"e0224952","DOI":"10.1371\/journal.pone.0224952","article-title":"Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization","volume":"15","author":"Yadikar","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0800","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43088-022-00223-1","article-title":"The role of protein phosphatase 2A tau axis in traumatic brain injury therapy","volume":"11","author":"Mahamane Salissou","year":"2022","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"key":"10.1016\/j.neulet.2023.137532_b0805","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.015574","article-title":"Protein phosphatase PPM1B inhibits DYRK1A kinase through dephosphorylation of pS258 and reduces toxic tau aggregation","volume":"296","author":"Lee","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2023.137532_b0810","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ijbiomac.2020.07.327","article-title":"Role of tau protein in Alzheimer's disease: The prime pathological player","volume":"163","author":"Muralidar","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2\u20133","key":"10.1016\/j.neulet.2023.137532_b0815","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bbadis.2004.08.009","article-title":"Regulation of tau isoform expression and dementia","volume":"1739","author":"D'Souza","year":"2005","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"17","key":"10.1016\/j.neulet.2023.137532_b0820","doi-asserted-by":"crossref","first-page":"9207","DOI":"10.3390\/ijms22179207","article-title":"Tau protein interaction partners and their roles in Alzheimer\u2019s disease and other tauopathies","volume":"22","author":"Sinsky","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0825","doi-asserted-by":"crossref","first-page":"e1008267","DOI":"10.1371\/journal.pcbi.1008267","article-title":"Protein-protein interactions in neurodegenerative diseases: A conspiracy theory","volume":"16","author":"Thompson","year":"2020","journal-title":"PLoS Comput. Biol."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0830","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3233\/JAD-180656","article-title":"A review of the familial Alzheimer\u2019s disease locus PRESENILIN 2 and its relationship to PRESENILIN 1","volume":"66","author":"Jiang","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"23","key":"10.1016\/j.neulet.2023.137532_b0835","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1021\/acs.jpcb.0c01712","article-title":"Identification of Structural Calcium Binding Sites in Membrane-Bound Presenilin 1 and 2","volume":"124","author":"Mehra","year":"2020","journal-title":"J. Phys. Chem. B"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0840","doi-asserted-by":"crossref","first-page":"e0265022","DOI":"10.1371\/journal.pone.0265022","article-title":"Discovery of novel benzophenone integrated derivatives as anti-Alzheimer\u2019s agents targeting presenilin-1 and presenilin-2 inhibition: A computational approach","volume":"17","author":"Martiz","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0845","doi-asserted-by":"crossref","first-page":"5140","DOI":"10.3390\/ijms22105140","article-title":"Alzheimer\u2019s disease associated presenilin 1 and 2 genes dysregulation in neonatal lymphocytes following perinatal asphyxia","volume":"22","author":"Tarkowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.neulet.2023.137532_b0850","doi-asserted-by":"crossref","first-page":"10970","DOI":"10.3390\/ijms231810970","article-title":"Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene","volume":"23","author":"Bagaria","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0855","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/acn3.755","article-title":"Alternative splicing in a presenilin 2 variant associated with Alzheimer disease","volume":"6","author":"Braggin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"24","key":"10.1016\/j.neulet.2023.137532_b0860","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1074\/jbc.M115.708297","article-title":"Presenilin 1 and presenilin 2 target \u03b3-secretase complexes to distinct cellular compartments","volume":"291","author":"Meckler","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2023.137532_b0865","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-016-0281-8","article-title":"Presenilin 1 transgene addition to amyloid precursor protein overexpressing transgenic rats increases amyloid beta 42 levels and results in loss of memory retention","volume":"17","author":"Agca","year":"2016","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b0870","doi-asserted-by":"crossref","unstructured":"Kelleher III, R.J. and J. Shen, Presenilin-1 mutations and Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences, 2017. 114(4): p. 629-631.","DOI":"10.1073\/pnas.1619574114"},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b0875","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1534\/genetics.115.182808","article-title":"A \u03b3-secretase independent role for presenilin in calcium homeostasis impacts mitochondrial function and morphology in Caenorhabditis elegans","volume":"201","author":"Sarasija","year":"2015","journal-title":"Genetics"},{"key":"10.1016\/j.neulet.2023.137532_b0880","series-title":"Seminars in Cell & Developmental Biology","article-title":"Contribution of the Presenilins in the cell biology, structure and function of \u03b3-secretase","author":"Escamilla-Ayala","year":"2020"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0885","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s42003-023-04539-1","article-title":"Effects of presenilin-1 familial Alzheimer\u2019s disease mutations on \u03b3-secretase activation for cleavage of amyloid precursor protein","volume":"6","author":"Do","year":"2023","journal-title":"Communications Biology"},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b0890","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1038\/s41380-020-0856-8","article-title":"Presenilin 1 phosphorylation regulates amyloid-\u03b2 degradation by microglia","volume":"26","author":"Ledo","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2023.137532_b0895","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2021.02.025","article-title":"Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro","volume":"103","author":"Cash","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-019-0501-9","article-title":"Presenilin1 exerts antiproliferative effects by repressing the Wnt\/\u03b2-catenin pathway in glioblastoma","volume":"18","author":"Yang","year":"2020","journal-title":"Cell Communication and Signaling"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0905","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1038\/s41598-018-26888-2","article-title":"Novel interaction between Alzheimer\u2019s disease-related protein presenilin 1 and glutamate transporter 1","volume":"8","author":"Zoltowska","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neulet.2023.137532_b0910","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.biopsych.2017.04.011","article-title":"\u03b2-Amyloid precursor protein intracellular domain controls mitochondrial function by modulating phosphatase and tensin homolog\u2013induced kinase 1 transcription in cells and in Alzheimer mice models","volume":"83","author":"Goiran","year":"2018","journal-title":"Biol. Psychiatry"},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0915","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/antiox11091642","article-title":"Deregulation of mitochondrial calcium handling due to presenilin loss disrupts redox homeostasis and promotes neuronal dysfunction","volume":"11","author":"Ryan","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neulet.2023.137532_b0920","doi-asserted-by":"crossref","unstructured":"Guo, Q., J. Xie, and C.J. Guo, Par-4 in neuronal death and survival in Alzheimer\u2019s disease and other neurogenerative diseases. Tumor Suppressor Par-4: Role in Cancer and Other Diseases, 2021: p. 215-245.","DOI":"10.1007\/978-3-030-80558-6_14"},{"key":"10.1016\/j.neulet.2023.137532_b0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-0358-9","article-title":"Therapeutic approaches targeting Apolipoprotein E function in Alzheimer\u2019s disease","volume":"15","author":"Williams","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.neulet.2023.137532_b0930","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2020.00754","article-title":"The important interface between apolipoprotein E and neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Kloske","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b0935","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00018-022-04516-7","article-title":"Functional diversity of apolipoprotein E: from subcellular localization to mitochondrial function","volume":"79","author":"Rueter","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"21","key":"10.1016\/j.neulet.2023.137532_b0940","doi-asserted-by":"crossref","first-page":"11582","DOI":"10.3390\/ijms222111582","article-title":"Isoform-specific effects of apolipoprotein E on hydrogen peroxide-induced apoptosis in human induced pluripotent stem cell (iPSC)-derived cortical neurons","volume":"22","author":"Gao","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104795","article-title":"Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer's disease","volume":"138","author":"Butterfield","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0950","doi-asserted-by":"crossref","first-page":"87","DOI":"10.14336\/AD.2021.0616","article-title":"Alzheimer disease: recent updates on apolipoprotein E and gut microbiome mediation of oxidative stress, and prospective interventional agents","volume":"13","author":"Botchway","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.neulet.2023.137532_b0955","first-page":"83","article-title":"Interactions between apolipoprotein E, sex, and amyloid-beta on cerebrospinal fluid p-tau levels in the European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS)","author":"Saunders","year":"2022","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b0960","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.apsb.2021.10.002","article-title":"Apolipoprotein E and Alzheimer's disease","volume":"12","author":"Troutwine","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.neulet.2023.137532_b0965","doi-asserted-by":"crossref","first-page":"1134399","DOI":"10.3389\/fnagi.2023.1134399","article-title":"Association of candidate genetic variants and circulating levels of ApoE\/ApoJ with common neuroimaging features of cerebral amyloid angiopathy","volume":"15","author":"Bonaterra-Pastra","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"17","key":"10.1016\/j.neulet.2023.137532_b0970","doi-asserted-by":"crossref","first-page":"9892","DOI":"10.3390\/ijms23179892","article-title":"Apolipoprotein E in cardiometabolic and neurological health and diseases","volume":"23","author":"Alagarsamy","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b0975","article-title":"Dissecting the association of apolipoprotein E gene polymorphisms with type 2 diabetes mellitus and coronary artery disease","volume":"13","author":"Wu","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.neulet.2023.137532_b0980","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neurobiolaging.2022.03.011","article-title":"ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease","volume":"115","author":"Li","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2023.137532_b0985","doi-asserted-by":"crossref","unstructured":"Ayyubova, G., APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 2023.","DOI":"10.2174\/1871527322666230303114425"},{"key":"10.1016\/j.neulet.2023.137532_b0990","first-page":"1","article-title":"Roles of ApoE4 on the Pathogenesis in Alzheimer\u2019s Disease and the Potential Therapeutic Approaches","author":"Sun","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b0995","doi-asserted-by":"crossref","first-page":"e0280178","DOI":"10.1371\/journal.pone.0280178","article-title":"Development of a simple screening tool for determining cognitive status in Alzheimer\u2019s disease","volume":"18","author":"Chang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2023.137532_b1000","doi-asserted-by":"crossref","unstructured":"Rodriguez-Rivera, C., et al., Clusterin: Always protecting. Synthesis, function and potential issues. Biomedicine & Pharmacotherapy, 2021. 134: p. 111174.","DOI":"10.1016\/j.biopha.2020.111174"},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b1005","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4103\/1673-5374.301013","article-title":"Clusterin: a multifaceted protein in the brain","volume":"16","author":"Moon","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neulet.2023.137532_b1010","doi-asserted-by":"crossref","DOI":"10.1177\/1177271920964108","article-title":"Clusterin as a potential biomarker of obesity-related Alzheimer\u2019s disease risk","volume":"15","author":"Bradley","year":"2020","journal-title":"Biomark. Insights"},{"issue":"8","key":"10.1016\/j.neulet.2023.137532_b1015","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.tibs.2021.01.005","article-title":"The dual roles of clusterin in extracellular and intracellular proteostasis","volume":"46","author":"Satapathy","year":"2021","journal-title":"Trends Biochem. Sci"},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b1020","article-title":"Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?","volume":"1868","author":"Spatharas","year":"2022","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"issue":"10","key":"10.1016\/j.neulet.2023.137532_b1025","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/biom12101452","article-title":"The Role of Clusterin Transporter in the Pathogenesis of Alzheimer\u2019s Disease at the Blood-Brain Barrier Interface: A Systematic Review","volume":"12","author":"Fareed","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.neulet.2023.137532_b1030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s11064-020-03176-y","article-title":"Single nucleotide polymorphism rs11136000 of CLU gene (Clusterin, ApoJ) and the risk of late-onset Alzheimer\u2019s disease in a Central European Population","volume":"46","author":"Balcar","year":"2021","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neulet.2023.137532_b1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbas.2023.100080","article-title":"Monitoring clusterin and fibrillar structures in aging and dementia","volume":"3","author":"Trindade","year":"2023","journal-title":"Aging Brain"},{"key":"10.1016\/j.neulet.2023.137532_b1040","doi-asserted-by":"crossref","first-page":"1056184","DOI":"10.3389\/fgene.2022.1056184","article-title":"A pan-cancer analysis reveals role of clusterin (CLU) in carcinogenesis and prognosis of human tumors","volume":"13","author":"Fu","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.neulet.2023.137532_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2023.103843","article-title":"Identification of cytoskeletal proteins as binding partners of Bri2 BRICHOS domain","volume":"125","author":"Shimozawa","year":"2023","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/21655979.2020.1868732","article-title":"Clinical importance of serum secreted clusterin in predicting invasive breast cancer and treatment responses","volume":"12","author":"Chen","year":"2021","journal-title":"Bioengineered"},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b1055","doi-asserted-by":"crossref","first-page":"2100287","DOI":"10.1002\/bies.202100287","article-title":"The chaperone Clusterin in neurodegeneration\u2212 friend or foe?","volume":"44","author":"Yuste-Checa","year":"2022","journal-title":"Bioessays"},{"issue":"9","key":"10.1016\/j.neulet.2023.137532_b1060","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1172\/JCI9037","article-title":"Apolipoprotein J\/clusterin limits the severity of murine autoimmune myocarditis","volume":"106","author":"McLaughlin","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neulet.2023.137532_b1065","doi-asserted-by":"crossref","first-page":"e48255","DOI":"10.7554\/eLife.48255","article-title":"Brain clusterin protein isoforms and mitochondrial localization","volume":"8","author":"Herring","year":"2019","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1070","doi-asserted-by":"crossref","first-page":"18639","DOI":"10.1038\/s41598-022-23167-z","article-title":"Glycosylated clusterin species facilitate A\u03b2 toxicity in human neurons","volume":"12","author":"Foster","year":"2022","journal-title":"Sci. Rep."},{"issue":"33","key":"10.1016\/j.neulet.2023.137532_b1075","doi-asserted-by":"crossref","first-page":"E6962","DOI":"10.1073\/pnas.1701137114","article-title":"Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways","volume":"114","author":"Wojtas","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b1080","article-title":"Molecular mechanisms and genetics of Alzheimer\u2019s disease. Turkish","author":"\u00d6ztan","year":"2023","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b1085","doi-asserted-by":"crossref","first-page":"882","DOI":"10.30574\/wjarr.2023.17.2.20200335","article-title":"Advances in the pathogenesis of Alzheimer\u2019s disease: A re-evaluation of the Amyloid cascade hypothesis","volume":"17","author":"Chukwu","year":"2023","journal-title":"World Journal of Advanced Research and Reviews"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1090","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","article-title":"Mitophagy in Alzheimer\u2019s disease: Molecular defects and therapeutic approaches","volume":"28","author":"Mary","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2023.137532_b1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurol.2022.12.006","article-title":"Beyond the amyloid cascade: An update of Alzheimer's disease pathophysiology","author":"Gouilly","year":"2023","journal-title":"Rev. Neurol."},{"issue":"26","key":"10.1016\/j.neulet.2023.137532_b1100","first-page":"4","article-title":"Theoretical justification of a purposeful search of potential neurotropic drugs. ScienceRise: Pharmaceutical","volume":"4","author":"Semenets","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neulet.2023.137532_b1105","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108352","article-title":"Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease","volume":"190","author":"Marucci","year":"2021","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.neulet.2023.137532_b1110","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.3390\/molecules25174005","article-title":"Memantine derivatives as multitarget agents in Alzheimer\u2019s disease","volume":"25","author":"Marotta","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.neulet.2023.137532_b1115","article-title":"The effect of \u03b1-tocopherol, \u03b1-and \u03b3-tocotrienols on amyloid-\u03b2 aggregation and disaggregation in vitro","volume":"28","author":"Ibrahim","year":"2021","journal-title":"Biochem. Biophys. Rep."},{"issue":"11","key":"10.1016\/j.neulet.2023.137532_b1120","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1080\/1028415X.2021.1956848","article-title":"Functional role of ascorbic acid in the central nervous system: A focus on neurogenic and synaptogenic processes","volume":"25","author":"Moretti","year":"2022","journal-title":"Nutr. Neurosci."},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b1125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/antiox11020213","article-title":"Naturally occurring antioxidant therapy in Alzheimer\u2019s disease","volume":"11","author":"Collins","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.neulet.2023.137532_b1130","first-page":"105","article-title":"Alzheimer\u2019s disease therapeutic approaches","author":"Revi","year":"2020","journal-title":"GeNeDis 2018: Genetics and Neurodegeneration"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/ejnf.2020.95797","article-title":"Effect of coenzyme Q10 and L-carnitine on growth performance, physical and chemical blood indices, antioxidant status and immune response of newborn Egyptian buffalo calves","volume":"23","author":"Gabr","year":"2020","journal-title":"Egyptian Journal of Nutrition and Feeds"},{"key":"10.1016\/j.neulet.2023.137532_b1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2021.118071","article-title":"Early detection of Alzheimer's disease using creatine chemical exchange saturation transfer magnetic resonance imaging","volume":"236","author":"Chen","year":"2021","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer\u2019s disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Translational Neurodegeneration"},{"key":"10.1016\/j.neulet.2023.137532_b1150","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.735928","article-title":"Nerve Growth Factor-Based Therapy in Alzheimer\u2019s Disease and Age-Related Macular Degeneration","volume":"15","author":"Amadoro","year":"2021","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2023.137532_b1155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fnins.2020.00157","article-title":"The effect of estrogen replacement therapy on Alzheimer's disease and Parkinson's disease in postmenopausal women: a meta-analysis","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci."},{"issue":"18","key":"10.1016\/j.neulet.2023.137532_b1160","doi-asserted-by":"crossref","first-page":"9987","DOI":"10.3390\/ijms22189987","article-title":"Insulin and insulin resistance in Alzheimer\u2019s disease","volume":"22","author":"S\u0119dzikowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.neulet.2023.137532_b1165","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2174\/1567205017666201127163018","article-title":"Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of Alzheimer\u2019s disease: do they still have a role?","volume":"17","author":"Villarejo-Galende","year":"2020","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neulet.2023.137532_b1170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102294","article-title":"Oxidative stress in alzheimer\u2019s disease: A review on emergent natural polyphenolic therapeutics","volume":"49","author":"Cassidy","year":"2020","journal-title":"Complement. Ther. Med."},{"issue":"15","key":"10.1016\/j.neulet.2023.137532_b1175","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.3390\/ijms22158208","article-title":"Novel therapeutic approaches for Alzheimer\u2019s disease: An updated review","volume":"22","author":"Yu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2022.101144","article-title":"Diagnostic and therapeutic potential of protease inhibition","volume":"88","author":"\u0106wilichowska","year":"2022","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.neulet.2023.137532_b1185","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113188","article-title":"The role and therapeutic implication of protein tyrosine phosphatases in Alzheimer\u2019s disease","volume":"151","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.neulet.2023.137532_b1190","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.3390\/ijms21249677","article-title":"c-Jun N-terminal kinase inhibitors as potential leads for new therapeutics for Alzheimer\u2019s diseases","volume":"21","author":"Hepp Rehfeldt","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neulet.2023.137532_b1195","first-page":"1","article-title":"Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer\u2019s disease? From preclinical studies to the clinical trials","author":"Basheer","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.neulet.2023.137532_b1200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jagp.2021.04.014","article-title":"Low dose lithium treatment of behavioral complications in Alzheimer's disease: lit-AD randomized clinical trial","volume":"30","author":"Devanand","year":"2022","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"11","key":"10.1016\/j.neulet.2023.137532_b1205","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.3390\/cells12111478","article-title":"Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson\u2019s and Alzheimer\u2019s Disease Therapy","volume":"12","author":"Senevirathne","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.neulet.2023.137532_b1210","doi-asserted-by":"crossref","first-page":"e13995","DOI":"10.1111\/eci.13995","article-title":"Deep brain stimulation of fornix in Alzheimer's disease: from basic research to clinical practice","author":"Liu","year":"2023","journal-title":"Eur. J. Clin. Invest."},{"issue":"7","key":"10.1016\/j.neulet.2023.137532_b1215","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"2","key":"10.1016\/j.neulet.2023.137532_b1220","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/WNF.0b013e3181cb577a","article-title":"Safety and changes in plasma and cerebrospinal fluid amyloid \u03b2 after a single administration of an amyloid \u03b2 monoclonal antibody in subjects with Alzheimer disease","volume":"33","author":"Siemers","year":"2010","journal-title":"Clin. Neuropharmacol."},{"issue":"4","key":"10.1016\/j.neulet.2023.137532_b1225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.biopsych.2017.08.010","article-title":"Anti-Amyloid-\u03b2 Monoclonal Antibodies for Alzheimer\u2019s Disease: Pitfalls and Promise","volume":"83","author":"van Dyck","year":"2018","journal-title":"Biol. Psychiatry"}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394023004913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:11:41Z","timestamp":1736359901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394023004913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":245,"alternative-id":["S0304394023004913"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137532","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer's disease: The role of proteins in formation, mechanisms, and new therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2023.137532","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"137532"}}